Allakos Financial Statements From 2010 to 2026
| ALLKDelisted Stock | USD 0.33 0.00 0.00% |
Check Allakos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allakos' main balance sheet or income statement drivers, such as , as well as many indicators such as . Allakos financial statements analysis is a perfect complement when working with Allakos Valuation or Volatility modules.
Allakos |
Allakos Company Shares Owned By Insiders Analysis
Allakos' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Allakos Shares Owned By Insiders | 1.96 % |
Most of Allakos' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allakos is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 1.96% of Allakos are shares owned by insiders. This is 87.09% lower than that of the Biotechnology sector and 86.18% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 80.57% higher than that of the company.
Allakos Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allakos's current stock value. Our valuation model uses many indicators to compare Allakos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allakos competition to find correlations between indicators driving Allakos's intrinsic value. More Info.Allakos is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Allakos by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Allakos Financial Statements
Allakos investors utilize fundamental indicators, such as revenue or net income, to predict how Allakos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California. Allakos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Allakos Stock
If you are still planning to invest in Allakos check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allakos' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |